Evidence map›Paper›PMID 17885691›Full record

GuidelineCanadian respiratory journal2007

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.

Denis E O'Donnell, Shaw Aaron, Jean Bourbeau, Paul Hernandez, Darcy D Marciniuk, Meyer Balter, Gordon Ford, Andre Gervais, Rogers Goldstein, Rick Hodder and 9 more

Registry-linked trialAbstract readCase ReportsPractice GuidelineReview
In one paragraph

Guideline in Canadian respiratory journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03772626 (The Feasibility and Efficacy of Heated Humidified Nasal Cannula), which is not on this map. Cited by 139 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03772626 naunknown statusnot on this mapstarted 2019, after this paper: background citation

The Feasibility and Efficacy of Heated Humidified Nasal Cannula (AIRVOTM) in Hospital and at Home - An Open-Label, Non-Randomized Pilot Study.

TypeinterventionalSponsorMcMaster UniversityRan2019 to 2022Enrolled30ConditionsCOPD ExacerbationArmsHeated Humidified High-flow Nasal Cannula
3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pulmonary rehabilitation for chronic obstructive pulmonary disease.The Cochrane database of systematic reviews · 2015
    Pooled it
  3. Guideline
  4. Pooled it
  5. Guideline
  6. Guideline
  7. Guideline
  8. Guideline
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.International journal of chronic obstructive pulmonary disease · 2011
    Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Denis E O'DonnellQueen's University, Kingston, Canada.
Shaw Aaron
Jean Bourbeau
Paul Hernandez
Darcy D Marciniuk
Meyer Balter
Gordon Ford
Andre Gervais
Rogers Goldstein
Rick Hodder
Alan Kaplan
Sean Keenan
Yves Lacasse
Francois Maltais
Jeremy Road
Graeme Rocker
Don Sin
Tasmin Sinuff
Nha Voduc

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Canada that is both preventable and treatable. Our understanding of the pathophysiology of this complex condition continues to grow and our ability to offer effective treatment to those who suffer from it has improved considerably. The purpose of the present educational initiative of the Canadian Thoracic Society (CTS) is to provide up to date information on new developments in the field so that patients with this condition will receive optimal care that is firmly based on scientific evidence. Since the previous CTS management recommendations were published in 2003, a wealth of new scientific information has become available. The implications of this new knowledge with respect to optimal clinical care have been carefully considered by the CTS Panel and the conclusions are presented in the current document. Highlights of this update include new epidemiological information on mortality and prevalence of COPD, which charts its emergence as a major health problem for women; a new section on common comorbidities in COPD; an increased emphasis on the meaningful benefits of combined pharmacological and nonpharmacological therapies; and a new discussion on the prevention of acute exacerbations. A revised stratification system for severity of airway obstruction is proposed, together with other suggestions on how best to clinically evaluate individual patients with this complex disease. The results of the largest randomized clinical trial ever undertaken in COPD have recently been published, enabling the Panel to make evidence-based recommendations on the role of modern pharmacotherapy. The Panel hopes that these new practice guidelines, which reflect a rigorous analysis of the recent literature, will assist caregivers in the diagnosis and management of this common condition.

Indexed as

Oxygen Inhalation TherapyAdrenal Cortex HormonesAgedBronchodilator AgentsCanadaFemaleHumansMaleMiddle AgedPulmonary Disease, Chronic ObstructiveSmoking CessationAdrenal Cortex HormonesBronchodilator Agents

Identifiers

PMID17885691
PMCPMC2806792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.